logo
Share SHARE
FONT-SIZE Plus   Neg

VSE Global Division Retains U.S. Naval Sea Systems Contract - Update

VSE Corp. (VSEC) Monday said its global division has retained a one-year $277 million cost-plus-award-fee, contract by the U.S. Naval Sea Systems Command as the U.S. Government Accountability Office denied a protest to the award of the contract to the company.

The indefinite-delivery, indefinite-quantity contract, having five-year maximum potential of $1.5 billion, was announced originally on October 3, 2011.

The contract is for continuous lifecycle support of naval vessels bought, sold, or otherwise transferred to Foreign Military Sales customers through the International Fleet Support Program.

VSE will lead its Naval Ship Transfer and Repair team with services to foreign customers and allies, including design, configuration management, field engineering, maintenance planning and maintenance, among others.

In addition, the team will provide engineering, technical, procurement, logistics, test, inspection, calibration, repair, maintenance, equipment upgrade installation, and overhaul support services.

Raytheon, Science Applications International Corp., Thales Naval, Inc., Lockheed Martin, Computer Sciences Corp. and BAE Systems are some of the other team members.

VSE has been performing Ship Transfer and Follow-on Technical Support work for the Naval Sea Systems Command since 1995.

VSEC closed on Friday at $25.76, up from the prior close of $25.11, on 3,800 shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) Friday said its first-quarter profit rose from last year, as revenues increased. However, the company's operating profit dropped hurt by derivative losses and lower railroad revenues. Berkshire is a holding company with a number... Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor? Shares of steel giant ArcelorMittal were losing around 4 percent in the early morning trading in Amsterdam after the company reported sharp decline in first-quarter EBITDA, a key earnings metric, as sales were weak with lower prices and production. Net loss, however, narrowed from last year. The company also confirmed its forecast for annual EBITDA, which is lower than last year.
comments powered by Disqus
Follow RTT